We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+9.46%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$46.4B
AUM Growth
+$1.57B
Cap. Flow
-$1.94B
Cap. Flow %
-4.18%
Top 10 Hldgs %
15.88%
Holding
3,334
New
229
Increased
1,188
Reduced
1,323
Closed
158

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$199M
2
TSM icon
TSMC
TSM
+$163M
3
AMZN icon
Amazon
AMZN
+$99.6M
4
META icon
Meta Platforms (Facebook)
META
+$89.1M
5
MELI icon
Mercado Libre
MELI
+$73M

Sector Composition

Rank Sector Weight
1 Technology 19.84%
2 Consumer Discretionary 13.42%
3 Financials 12.84%
4 Healthcare 12.47%
5 Real Estate 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LJPC
3051
DELISTED
La Jolla Pharmaceutical Company
LJPC
$22K ﹤0.01%
5,568
EVC icon
3052
Entravision Communication
EVC
$850M
$20K ﹤0.01%
13,687
RNAC icon
3053
Cartesian Therapeutics
RNAC
$260M
$20K ﹤0.01%
278
ADMS
3054
DELISTED
Adamas Pharmaceuticals
ADMS
$19K ﹤0.01%
4,814
BCBP icon
3055
BCB Bancorp
BCBP
$158M
$18K ﹤0.01%
2,308
-23,877
-91% -$200K
CRNX icon
3056
Crinetics Pharmaceuticals
CRNX
$8.95B
$18K ﹤0.01%
1,200
-4,400
-79% -$67.3K
CBIO
3057
Crescent Biopharma
CBIO
$620M
$18K ﹤0.01%
61
-163
-73% -$62.3K
CGC
3058
Canopy Growth
CGC
$422M
$17K ﹤0.01%
122
ESSA
3059
DELISTED
ESSA Bancorp
ESSA
$17K ﹤0.01%
1,400
-301
-18% -$3.92K
CPIX icon
3060
Cumberland Pharmaceuticals
CPIX
$119M
$16K ﹤0.01%
5,198
AMRN
3061
Amarin Corp
AMRN
$296M
$15K ﹤0.01%
196
-1,043
-84% -$125K
PXLW icon
3062
Pixelworks
PXLW
$38.3M
$15K ﹤0.01%
640
FRO icon
3063
Frontline
FRO
$8.49B
$13K ﹤0.01%
2,082
GYRE icon
3064
Gyre Therapeutics
GYRE
$704M
$13K ﹤0.01%
418
VAL
3065
DELISTED
Valaris plc Class A Ordinary Share
VAL
$13K ﹤0.01%
165,968
-88,000
-35% -$47.6K
BB icon
3066
BlackBerry
BB
$5.26B
$12K ﹤0.01%
2,800
-4,040
-59% -$19.6K
FULC icon
3067
Fulcrum Therapeutics
FULC
$282M
$10K ﹤0.01%
1,300
SIRE
3068
DELISTED
Sisecam Resources LP
SIRE
0
LGF.B
3069
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$8K ﹤0.01%
1,015
CZZ
3070
DELISTED
Cosan Limited
CZZ
$8K ﹤0.01%
624
SDGR icon
3071
Schrodinger
SDGR
$1.4B
$7K ﹤0.01%
152
-45,419
-100% -$3.12M
PAMT
3072
PAMT Corp
PAMT
$281M
$7K ﹤0.01%
800
FFNW
3073
DELISTED
First Financial Northwest, Inc
FFNW
$7K ﹤0.01%
800
QEP
3074
DELISTED
QEP RESOURCES, INC.
QEP
$7K ﹤0.01%
7,600
OXY.WS icon
3075
Occidental Petroleum Corp Warrants
OXY.WS
$34.8B
0

Similar funds

Russell Investments Group's Q3 2020 Portfolio in Review

As of Q3 2020, Russell Investments Group held 3,334 positions worth $46.4B, up 3.5% from $44.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Russell Investments Group withdrew a net $1.94B in Q3 2020, closing 158 positions and reducing 1,323 holdings. Its most notable exit was State Street Energy Select Sector SPDR ETF, an estimated $23.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Russell Investments Group opened a new position in iShares MSCI USA Value Factor ETF worth $58.4M.

  • Russell Investments Group's largest Q3 2020 buy was iShares MSCI USA Value Factor ETF: 791,800 shares worth $58.4M.
  • Russell Investments Group added most to Match Group in Q3 2020, an estimated $79.2M increase.
  • Russell Investments Group's biggest Q3 2020 reduction was Apple, cutting an estimated $199M.
  • Russell Investments Group fully exited State Street Energy Select Sector SPDR ETF in Q3 2020, selling an estimated $23.9M.
  • Russell Investments Group's ten largest holdings make up 16% of its $46.4B portfolio in Q3 2020.
  • Russell Investments Group opened 229 new positions and closed 158 in Q3 2020.
  • Russell Investments Group's portfolio value rose 3.5% quarter-over-quarter to $46.4B.

Based on Russell Investments Group's 13F filing for Q3 2020, filed 9 Nov 2020.